Acera Surgical
Acera Surgical Inc. is a St. Louis, Missouri bioscience company founded in 2013 that develops and commercializes fully engineered, 100% synthetic materials for regenerative wound care and soft tissue repair, built on a proprietary electrospun nanofiber technology platform. Its Restrata product family — Restrata Sheet, Restrata Meshed and Restrata MiniMatrix — is a fully resorbable synthetic matrix used to treat hard-to-heal and complex wounds in acute care settings, and its Cerafix implant addresses dural repair and cerebrospinal fluid leakage. Acera was acquired by Solventum Corporation on December 23, 2025 for $725 million in cash plus up to $125 million in milestone payments, and now sits inside Solventum's Medical segment MedSurg portfolio. Acera is a medical device manufacturer, not a software company: it publishes no API, developer portal, SDK, or machine-readable interface of any kind.
Acera Surgical is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Regenerative Medicine, Wound Care, and Biotechnology.
Acera Surgical’s developer surface includes support and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.